Trial intelligence / Profile preview

Nystatin plus hydrocortisone acetate paste versus nystatin paste for inflamed cutaneous candidiasis

2006-004759-39Phase 3Completed

Sponsor
Dermapharm
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in cutaneous candidiasis comparing Nystatin + hydrocortisone acetate paste with Nystatin paste (2 arms). Primary endpoint: Reduction in inflammation sum score from day 0 to day 3. Started Oct 2007; status: completed.

02

Drugs

nystatinhydrocortisone
03

Conditions

cutaneous candidiasis

Beyond the preview

Go deeper on 2006-004759-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004759-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call